Keenova Therapeutics Plc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/26/25 Q3

ended 06/27/25 Q2

ended 03/28/25 Q1

ended 12/27/24 FY 2024

ended 09/27/24 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Amendment to registration of securities for employees

Business combination disclosure

Business combination disclosure

Business combination disclosure

Ownership Filter

Nielsen Henriette

Honczarenko Marek

Williamson Susan Ann

News Filter

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Mallinckrodt Reports Third Quarter 2025 Financial Results

Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Conflict Minerals disclosure

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC